LIPOCINE INC. Reimbursement Revenue (Deprecated 2018-01-31)
LIPOCINE INC. (LPCN) reported Reimbursement Revenue (Deprecated 2018-01-31) of $0 for the 3-month period ending 2016-09-30, per its 10-Q filed 2016-11-08.
Discontinued › Income Statement › Other Income
us-gaap:ReimbursementRevenue · last filed 2016-11-08
- LIPOCINE INC. reimbursement revenue (deprecated 2018-01-31) for the quarter ending 2016-09-30 was $0.00, a 100.00% decline year-over-year.
- LIPOCINE INC. reimbursement revenue (deprecated 2018-01-31) for the quarter ending 2016-06-30 was $3.10K.
- LIPOCINE INC. reimbursement revenue (deprecated 2018-01-31) for the quarter ending 2015-09-30 was $38.00K.
- LIPOCINE INC. reimbursement revenue (deprecated 2018-01-31) for the quarter ending 2015-06-30 was $0.00.
| Period end | Reimbursement Revenue (Deprecated 2018-01-31) 3 month | Reimbursement Revenue (Deprecated 2018-01-31) 6 month | Reimbursement Revenue (Deprecated 2018-01-31) 9 month |
|---|---|---|---|
| 2016-09-30 | $0.00 10-Q · filed 2016-11-08 | $3.10K derived: sum of 2 quarters · filed 2016-11-08 | $31.00K 10-Q · filed 2016-11-08 |
| 2016-06-30 | $3.10K 10-Q · filed 2016-08-09 | $3.10K 10-Q · filed 2016-08-09 | |
| 2015-09-30 | $38.00K 10-Q · filed 2016-11-08 | $38.00K derived: sum of 2 quarters · filed 2016-11-08 | $38.00K 10-Q · filed 2016-11-08 |
| 2015-06-30 | $0.00 10-Q · filed 2016-08-09 | $0.00 10-Q · filed 2016-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |